Figure 1.
Dyslipidemia at evaluation among all survivors and community controls, stratified by (A) sex and (B) race. A) Non-HDL is more likely to be elevated in male survivors vs controls. Low HDL is more likely to be elevated in both sexes in survivors vs controls. Triglycerides are more likely to be elevated in male survivors vs controls. B) Non-HDL is more likely to be elevated in Black and Hispanic survivors vs controls. aStatistically significant difference between same sex in community controls vs SJLIFE participants. bStatistically significant difference between same race in community controls vs SJ LIFE participants. HDL = high-density lipoprotein; LDL = low-density lipoprotein; SJLIFE = St. Jude Lifetime Cohort.

Dyslipidemia at evaluation among all survivors and community controls, stratified by (A) sex and (B) race. A) Non-HDL is more likely to be elevated in male survivors vs controls. Low HDL is more likely to be elevated in both sexes in survivors vs controls. Triglycerides are more likely to be elevated in male survivors vs controls. B) Non-HDL is more likely to be elevated in Black and Hispanic survivors vs controls. aStatistically significant difference between same sex in community controls vs SJLIFE participants. bStatistically significant difference between same race in community controls vs SJ LIFE participants. HDL = high-density lipoprotein; LDL = low-density lipoprotein; SJLIFE = St. Jude Lifetime Cohort.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close